Matches in SemOpenAlex for { <https://semopenalex.org/work/W3097788921> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W3097788921 endingPage "31" @default.
- W3097788921 startingPage "30" @default.
- W3097788921 abstract "HbS (HBB:c.20A>T, beta 6 Glu>Val) is a frequent Hb variant in Mexico, in particular in some regions close to the Pacific and Atlantic Oceans, with carrier frequencies from 0.5 to 12.8%, therefore Sickle Cell Disease patients are often seen in those regions. It is well known that increased levels of Fetal Hemoglobin (HbF) ameliorates the clinical complications of sickle cell disease. Several genetic studies have identifiedBCL11A,HBS1L-MYB(intergenic region),HBG2andHBBP1genes, among others, to be involved in HbF regulation; DNA variants in theselociare associated to elevated HbF. The aim of present study was to analyze 15 variants in HbF regulatorylociin Mexican patients with Sickle Cell Disease. About 10 mL of peripheral blood was collected in EDTA for hematological and molecular testing from 24 sickle cell anemia patients (S/S) and 15 sickle cell trait carriers (S/A) from Southern Mexico, 13 were from the state of Guerrero and 26 from Chiapas. All subjects voluntarily agreed to participate in this study and gave signed informed consent; underaged patients' consent was obtained from their parents; all procedures were performed according to the ethical principles of the Declaration of Helsinki. Hemoglobin S genotype was determined by Sanger sequencing; DNA variants genotyping was performed by qPCR using commercial Taqman probes for the following variants: inBCL11Ars11886868, rs4671393, rs7557939, rs1427407, rs766432, rs6706648, rs7599488; inHBS1L-MYBrs7776054, rs28384513, rs9399137, rs4895441, rs9402686, rs1320963, inHBG2rs7482144 and inHBBP1rs10128556. Hematological and clinical data were analyzed by IBM SPSS v24®. A total of 39 sickle cell patients were studied, twenty-one patients were male and 18 were female (53.8% and 46.2% respectively). Thirty-two were pediatric age patients and 7 adults. Anemia was observed in all S/S patients, eight had severe anemia (<8 g/dL); on the other hand, only 5/15 S/A patients had anemia (10 - 12 g/dL); HbF over 5% was observed in 23/24 S/S patients and in 13/15 S/A had HbF from 2% - 5%. Nineteen S/S patients were treated with hydroxyurea and presented less severe phenotype and more elevated HbF, however, the statistical analysis showed no significant differences (12.9%vs8.9%p=0.248) (Table 1). Genotype and allele frequencies are displayed in Table 2. All minor alleles were observed in frequencies over 0.05, the mo2st commonly observed minor allele wasBCL11Ars1427407 (0.69), and the less frequently observed wasHBBP1rs101028556 (0.08). The allele frequencies of four HbF regulating variants were significant different from those reported for Mexican ancestry population (MXL) in 1000 Genome database (rs11886868 C>T, rs4671393 A>G, rs7599488 C>T and rs10128556 C>T), however, the analyzed sample in this study is undersized and is not representative of the global Mexican population. No differences were observed when comparing allele frequencies from GuerrerovsChiapas patients, nor S/SvsS/A. The correlation analysis of minor allele count (MAC) and HbF demonstrated no association when comparing it to HbF levels. Likewise, the analysis was performed onBCL11AandHBS1L-MYBvariants and showed no significant correlations. There was also no correlation between MAC and the other hematological parameters (RBC, Hb, PCV, MCV and MCH). We report the first study of HbF regulating DNA variants in Mexican sickle cell disease patients. The preliminary analysis of HbFvsminor allele count showed no relation of total MAC and increased HbF, neither with the variants ofBCL11AorHBS1L-MYB. Disclosures No relevant conflicts of interest to declare." @default.
- W3097788921 created "2020-11-09" @default.
- W3097788921 creator A5008960984 @default.
- W3097788921 creator A5038919298 @default.
- W3097788921 creator A5045368434 @default.
- W3097788921 creator A5046254730 @default.
- W3097788921 creator A5067178742 @default.
- W3097788921 creator A5072878886 @default.
- W3097788921 creator A5089315645 @default.
- W3097788921 date "2020-11-05" @default.
- W3097788921 modified "2023-09-27" @default.
- W3097788921 title "DNA Variants Involved in Regulation of Fetal Hemoglobin in Mexican Patients with Sickle Cell Disease. a Preliminary Analysis" @default.
- W3097788921 doi "https://doi.org/10.1182/blood-2020-139812" @default.
- W3097788921 hasPublicationYear "2020" @default.
- W3097788921 type Work @default.
- W3097788921 sameAs 3097788921 @default.
- W3097788921 citedByCount "0" @default.
- W3097788921 crossrefType "journal-article" @default.
- W3097788921 hasAuthorship W3097788921A5008960984 @default.
- W3097788921 hasAuthorship W3097788921A5038919298 @default.
- W3097788921 hasAuthorship W3097788921A5045368434 @default.
- W3097788921 hasAuthorship W3097788921A5046254730 @default.
- W3097788921 hasAuthorship W3097788921A5067178742 @default.
- W3097788921 hasAuthorship W3097788921A5072878886 @default.
- W3097788921 hasAuthorship W3097788921A5089315645 @default.
- W3097788921 hasBestOaLocation W30977889211 @default.
- W3097788921 hasConcept C104317684 @default.
- W3097788921 hasConcept C126322002 @default.
- W3097788921 hasConcept C135763542 @default.
- W3097788921 hasConcept C172680121 @default.
- W3097788921 hasConcept C203014093 @default.
- W3097788921 hasConcept C2776317666 @default.
- W3097788921 hasConcept C2777566322 @default.
- W3097788921 hasConcept C2778620579 @default.
- W3097788921 hasConcept C2779134260 @default.
- W3097788921 hasConcept C2779234561 @default.
- W3097788921 hasConcept C31467283 @default.
- W3097788921 hasConcept C54355233 @default.
- W3097788921 hasConcept C71924100 @default.
- W3097788921 hasConcept C86803240 @default.
- W3097788921 hasConceptScore W3097788921C104317684 @default.
- W3097788921 hasConceptScore W3097788921C126322002 @default.
- W3097788921 hasConceptScore W3097788921C135763542 @default.
- W3097788921 hasConceptScore W3097788921C172680121 @default.
- W3097788921 hasConceptScore W3097788921C203014093 @default.
- W3097788921 hasConceptScore W3097788921C2776317666 @default.
- W3097788921 hasConceptScore W3097788921C2777566322 @default.
- W3097788921 hasConceptScore W3097788921C2778620579 @default.
- W3097788921 hasConceptScore W3097788921C2779134260 @default.
- W3097788921 hasConceptScore W3097788921C2779234561 @default.
- W3097788921 hasConceptScore W3097788921C31467283 @default.
- W3097788921 hasConceptScore W3097788921C54355233 @default.
- W3097788921 hasConceptScore W3097788921C71924100 @default.
- W3097788921 hasConceptScore W3097788921C86803240 @default.
- W3097788921 hasIssue "Supplement 1" @default.
- W3097788921 hasLocation W30977889211 @default.
- W3097788921 hasOpenAccess W3097788921 @default.
- W3097788921 hasPrimaryLocation W30977889211 @default.
- W3097788921 hasRelatedWork W1493998812 @default.
- W3097788921 hasRelatedWork W1663907732 @default.
- W3097788921 hasRelatedWork W1891563673 @default.
- W3097788921 hasRelatedWork W1969105018 @default.
- W3097788921 hasRelatedWork W2807272258 @default.
- W3097788921 hasRelatedWork W2970312665 @default.
- W3097788921 hasRelatedWork W3012314541 @default.
- W3097788921 hasRelatedWork W3163831849 @default.
- W3097788921 hasRelatedWork W4240749157 @default.
- W3097788921 hasRelatedWork W4361279441 @default.
- W3097788921 hasVolume "136" @default.
- W3097788921 isParatext "false" @default.
- W3097788921 isRetracted "false" @default.
- W3097788921 magId "3097788921" @default.
- W3097788921 workType "article" @default.